跳至主要内容
临床试验/NCT01167673
NCT01167673Unknown2 期

A Double Blind Placebo Controlled Cross Over Study for the Use of Coltect (Green Tea, Selenium and Curcumin) in Irritable Bowel Syndrome

NAFTALI TIMNA1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2011年4月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
发起方
入组人数
40
试验地点
1
主要终点
improvement of IBS symptoms and quality of life

研究概览

简要总结

Irritable bowel syndrome (IBS) causes many symptoms, including abdominal pain, irregular bowel movements and bloating. It may be caused by loe degree inflammation of the intestine. The ingredients of coltect which contains green tea, selenium, and curcumin have been proven very safe and have anti inflammatory and anti oxidant activity. The aim of the study is to see whether the use of Coltect can improve symptoms in IBS patients.

详细描述

The etiology of Irritable bowel syndrome is unknown but some evidence suggests it may be caused by a certain degree of inflammation, another theory is that intestinal flora has an influence on IBS. Coltect combines 3 ingredients: green tea, selenium and curcumin, all of which have been shown to have anti inflammatory and anti oxidant activity. the aim of the study is to investigate if use of coltect can improve symptoms in IBS patients

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •IBS as defined by the Rome III criteria
  • •for those above age 40 a colonoscopy within the last 5 years
  • •no new treatment in the last 2 weeks
  • •not receiving any antibiotics in the last 2 weeks

排除标准

  • •any large abdominal operation (such as colectomy) in the past
  • •a known disease of the gastrointestinal tract
  • •any significant debilitating disease such as sever heart failure, un controlled diabetes,

研究组 & 干预措施

placebo

Placebo Comparator

patients receiving similar capsules but no active ingredients

干预措施: Placebo (Dietary Supplement)

treatment with study drug

Active Comparator

patients receiving study drug for 4 weeks. 3 capsules a day of coltect

干预措施: coltect (Dietary Supplement)

结局指标

主要结局

improvement of IBS symptoms and quality of life

时间窗: 10 weeks

improvement of IBS symptoms and quality of life (QOL) assessed by IBS and QOL questionaires.

次要结局

  • change in bacterial stool flora(10 weeks)

研究者

发起方
NAFTALI TIMNA
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

NAFTALI TIMNA

MD

Meir Medical Center

研究点 (1)

Loading locations...

相似试验